Period:
Draw Mode:
| Volume | 297,137 |
|
|||||
| News | - | ||||||
| Day High | 1.8756 | Low High |
|||||
| Day Low | 1.52 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aziyo Biologics Inc | AZYO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0899 | -5.17% | 1.6501 | 19:55:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.75 | 1.52 | 1.8756 | 1.59 | 1.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 890 | 297,137 | $ 1.69 | $ 503,511 | - | 1.10 - 9.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:37 | formt | 1,497 | $ 1.6501 | USD |
Aziyo Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 26.72M | 16.19M | 4.34M | $ 49.19M | $ -32.90M | -2.38 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 900.43k | 0.80% |
Aziyo Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AZYO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.17 | 1.95 | 1.10 | 1.47 | 1,861,014 | 0.4801 | 41.03% |
| 1 Month | 4.36 | 4.60 | 1.10 | 1.49 | 632,459 | -2.71 | -62.15% |
| 3 Months | 4.09 | 5.38 | 1.10 | 1.76 | 246,798 | -2.44 | -59.66% |
| 6 Months | 6.46 | 9.01 | 1.10 | 2.06 | 128,886 | -4.81 | -74.46% |
| 1 Year | 5.19 | 9.01 | 1.10 | 2.30 | 68,049 | -3.54 | -68.21% |
| 3 Years | 14.03 | 18.20 | 1.10 | 5.03 | 41,167 | -12.38 | -88.24% |
| 5 Years | 14.03 | 18.20 | 1.10 | 5.03 | 41,167 | -12.38 | -88.24% |
Aziyo Biologics Description
| Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. |